The effect of desmopressin in reducing the pain of renal colic patientsSearch for this on Google

The effect of adding sublingual desmopressin to the intravenous treatment with Apotel and ketorolac in patients with mild to moderate renal colic pain

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230704058673N1

Enrollment

102

Registered

2023-08-19

Start date

2023-07-21

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The effect of adding sublingual desmopressin to the intravenous treatment with Apotel and ketorolac in patients with mild to moderate renal colic pain.

Interventions

Intervention group:.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients with renal colic who have not received painkillers in the last three hours Do not have hypertension Do not have coronary artery disease Do not have gastric ulcers Do not have renal failure Do not have liver failure Do not pregnant Do not take anticoagulants

Exclusion criteria

Exclusion criteria: Patients who become unstable in terms of vital signs Have changes in blood pressure Tachycardia Headache dizziness seizure Occurrence of drug side effects Intolerance of pain during the study

Design outcomes

Primary

Measure	Time frame
Intensity of pain. Timepoint: zero, 15 minutes, 30 minutes, 45 minutes, 60 minutes,. Method of measurement: Using the visual analog scale (VAS) for this purpose, the printed VAS ruler is shown to the patients and they are asked to indicate the number that represents their current pain.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMojtaba Sasani

Ahvaz University of Medical Sciences

Drsasani72363@gmail.com+98 61 3571 5794

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026